Abstract: Medicinal Research ReviewsVolume 4, Issue 2 p. 153-188 Article Antitumor anthracyclines: Recent developments Federico Arcamone, Federico Arcamone Farmitalia Carlo Erba SpA, Chemical Research & Development, Via dei Gracchi, 35–20146 Milano, ItalySearch for more papers by this author Federico Arcamone, Federico Arcamone Farmitalia Carlo Erba SpA, Chemical Research & Development, Via dei Gracchi, 35–20146 Milano, ItalySearch for more papers by this author First published: April/June 1984 https://doi.org/10.1002/med.2610040203Citations: 81AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 F. Arcamone, G. Cassinelli, G. Franceschi, S. Penco, C. Pol, S. Redaelli, and A. Selva, International Symposium on Adriamycin, S. K. Carter, A. Di Marco, M. Ghione, I. H. Krakoff and F. Mathe, Eds., Springer Verlag, Berlin/Heidelberg/New York, 1972, pp. 9–22. 2 F. Arcamone, Doxorubicin, Medicinal Chemistry Series Vol. 17, G. Stevens, Ed., Academic, New York, 1981. 3 G. Cassinelli, G. Rivola, D. Ruggieri, C. Spalla, A. M. Casazza, A. Di Marco, and G. Pratesi, J. Antibiol., 35, 176 (1982). 4 S. T. Crooke, J. Med., 8, 295 (1977). 5 T. Oki, Anthracyclines: Current Status and New Developments, S. T. Crooke, Ed., Academic, New York, 1980, pp. 323–342. 6 M. B. Naff, J. Plowman, and V. L. Narayanan, Anthracycline Antibiotics, H. S. El Khadem, Ed., Academic, New York, 1982, p. 1. 7 R. C. Young, F. O. Robert, and C. E. Myers, New England J. Med., 305, 139 (1981). 8 F. Arcamone, E. Arlandini, M. Menozzi, L. Valentini, and E. Vannini, Anthracycline Antibiotics in Cancer Therapy, Developments in Oncology, Vol. 10, F. M. Muggia, C. W. Young and S. K. Carter, Eds., Martinus Nijhoff, 1982, pp. 79–85. 9 H. Schütz, F. A. Gollmick, and E. Stutter, Stud Biophys., 75, 147 (1979). 10 T. R. Krugh, Nuclear Magnetic Resonance Spectroscopy in Molecular Biology, B. Pullman, Ed., Dordrecht, Holland, 1979, pp. 137–146. 11 E. Stutter, F. A. Gollmick, and H. Schütz, Stud. Biophys., 88, 131 (1982). 12 E. Stutter and W. Förster, Stud. Biophys., 75, 199 (1979). 13 W. Förster, E. Stutter, and E. Bauer, Stud. Biophys., 79, 101 (1980). 14 E. Bauer, W. Förster and E. Stutter, Stud. Biophys., 81, 75 (1980). 15 E. Bauer, W. Förster and E. Stutter, Stud. Biophys., 81, 75 (1980). 16 S. Neidle and L. Taylor, FEBS Lett., 107, 348 (1979). 17 Y. Nakata and A. J. Hopfinger, FEBS Lett., 117, 259 (1980). 18 S. C. Brown, P. A. Kollman, and P. K. Weiner, Biochim. Biophys. Acta, 717, 49 (1982). 19 D. J. Patel and L. L. Canuel, Eur. J. Biochem., 90, 247 (1978). 20 D. J. Patel, Biopolymers, 18, 553 (1979). 21 D. J. Patel, S. A. Kozlowski, and J. A. Rice, Proc. Nat. Acad. Sci. USA, 78, 3333 (1981). 22 D. R. Phillips and G. C. K. Roberts, Biochemistry, 19, 4795 (1980). 23 M. E. Nuss, T. L. James, M. A. Apple, and P. A. Kollman, Biochim. Biophys. Acta, 609, 136 (1980). 24 W. D. Wilson and R. L. Jones, Nucleic Acids Res., 10, 1399 (1982). 25 M. Manfait, A. J. P. Alix, P. Jeannesson, J. C. Jardillier, and T. Theophanides, Nucleic Acids Res., 10, 3803 (1982). 26 M. J. Bell, G. W. Buchanan, B. R. Hollebone, and E. D. Jones, Can. J. Chem., 60, 291 (1982). 27 K. E. Reinert, Stud. Biophys., 87, 201 (1982). 28 K. E. Reinert, Stud. Biophys., 92, 63 (1982). 29 G. J. Quigley, A. H. J. Wang, G. Ughetto, G. Van der Marel, J. H. Van Boom, and A. Rich, Proc. Nat. Acad. Sci. USA, 77, 7204 (1980). 30 M. Grant and D. R. Phillips, Mol. Pharmacol., 16, 357 (1979). 31 S. Mong, V. H. DuVernay, J. E. Strong, and S. T. Crooke, Mol. Pharmacol., 17, 100 (1980). 32 D. Vedaldi, F. Dall'Acqua, S. Caffieri, and G. Rodighiero, Il Farmaco Ed. Sci., 37, 571 (1982). 33 J. B. Chaires, N. Dattagupta, and D. M. Crothers, Biochemistry, 21, 3933 (1982). 34 A. W. Prestayko, V. H. DuVernay, B. H. Long, and S. T. Crooke, see Ref. 8, p. 117. 35 M. M. Fishman and I. Schwartz, Biochem. Pharmacol., 23, 2147 (1974). 36 D. R. Phillips and G. A. Carlyle, Biochem. Pharmacol., 30, 2021 (1981). 37 M. Spinelli and J. C. Dabrowiak, Biochemistry, 21, 5862 (1982). 38 J. A. A. Schellinx, P. A. Dijkwel and F. Wanka, Eur. J. Biochem., 102, 409 (1979). 39 C. A. Maniglia and R. G. Wilson, Chem. Biol. Interact. 33, 319 (1981). 40 P. M. Kanter and H. S. Schwarts, Cancer Res., 39, 3661 (1979). 41 F. Zunino, A. Di Marco, A. Zaccara, and R. A. Gambetta, Biochim. Biophys. Acta, 607, 206 (1980). 42 H. Waldes and M. S. Center, Biochem. Biophys. Res. Commun., 98, 95 (1981). 43 H. Waldes and M. S. Center, Biochem. Pharmacol., 31, 1057 (1982). 44 P. D. Van Helden and I. J. F. Wiid, Biochem. Pharmacol., 31, 973 (1982). 45 S. C. Hixon, C. N. Ellis, and J. P. Daugherty, J. Mol. Cell. Cardiol., 13, 855 (1981). 46 F. Arcamone, A. Casazza, G. Cassinelli, A. Di Marco, and S. Penco, see Ref. 8, p. 179. 47 V. H. DuVernay, J. A. Pachter, and S. T. Crooke, Biochemistry, 18, 4024 (1979). 48 Y. Matsuzawa, T. Oki, T. Takeuchi, and H. Umezawa, J. Antibiot., 34, 1596 (1981). 49 J. A. Pachter, C. H. Huang, V. H. DuVernay, A. W. Prestayko, and S. T. Crooke, Biochemistry, 21, 1541 (1982). 50 V. H. Du Vernay, D. Eubanks, R. Perales, A. W. Prestayko, and S. T. Crooke, Mol. Pharmacol., 21, 196 (1981). 51 B. K. Sinha and C. F. Chignell, Chem. Biol. Interact. 28, 301 (1979). 52 A. Lucacchini, C. Martini, D. Segnini, and G. Ronca, Experientia, 35, 1148 (1979). 53 M. Yasumi, T. Minaga, K. Nakamura, A. Kizu, and H. Ijichi, Biochem. Biophys. Res. Commun. 93, 631 (1980). 54 F. L. Crane, W. C. MacKellar, D. J. Morre, T. Ramasarma, H. Goldenberg, C. Grebin, and H. Löw, Biochem. Biophys. Res. Commun., 93, 746 (1980). 55 W. Lewis, J. Kleinerman, and S. Puszkin, Circ. Res., 50, 547 (1982). 56 J. Fisher, K. Ramakrishnan, and K. E. McLane, Biochemistry, 24, 6172 (1982). 57 H. S. Schwartz and P. M. Kanter, Eur. J. Cancer, 15, 923 (1979). 58 G. S. Karczmar and T. R. Tritton, Biochim. Biophys. Acta, 557, 306 (1979). 59 E. Goormaghtigh, P. Chatelain, J. Caspers, and J. M. Ruysschaert, Biochim. Biophys. Acta, 597, 1 (1980). 60 E. Goormaghtigh, P. Chatelain, J. Caspers, and J. M. Ruysschaert, Biochem. Pharmacol., 29, 3003 (1980). 61 E. Goormaghtigh, M. Vandenbranden, J. M. Ruysschaert, and B. De Kruijff, Biochim. Biophys. Acta, 685, 137 (1982). 62 E. Goormaghtigh, R. Brasseur, and J. M. Ruysschaert, Biochem. Biophys. Res. Commun., 104, 314 (1982). 63 D. Pietronigro, J. E. McGinnes, M. J. Koren, R. Crippa, M. L. Seligman, and H. B. Demopoulos, Physiol. Chem. Phys., 11, 405 (1979). 64 D. Pietronigro, see Ref. 8, p. 220. 65 T. Komoyama, T. Oki, and T. Inui, J. Antibiot., 32, 1219 (1979). 66 J. W. Lown and H. H. Chen, Can. J. Chem., 59, 390 (1981). 67 E. D. Kharasch and R. F. Novak, Arch. Biochem. Biophys., 212, 20 (1981). 68 B. Kalyanaraman, E. Perez-Reyes, and R. P. Mason, Biochim. Biophys. Acta, 630, 119 (1980). 69 J. W. Lown and H. H. Chen, Can. J. Chem., 59, 3212 (1981). 70 T. Komiyama, T. Kikuchi, and Y. Sugiura, Biochem. Pharmacol., 31, 3651 (1982). 71 V. Berlin and W. A. Haseltine, J. Biol. Chem., 256, 4747 (1981). 72 C. C. Winterbourn, FEBS Lett., 136, 89 (1981). 73 E. G. Mimnaugh, M. A. Trush, and T. E. Gram, Biochem. Pharmacol., 30, 2797 (1981). 74 A. Bozzi, I. Mavelli, B. Mondovi, R. Strom, and G. Rotilio, Biochem. J., 194, 369 (1981). 75 B. A. Svingen, G. Powis, P. L. Appel, and M. Scott, Res. Commun. Chem. Phat. Pharmacol., 32, 189 (1981). 76 N. R. Bachur, M. V. Gee, and R. D. Friedman, Can. Res., 42, 1078 (1982). 77 D. Londos-Gagliardi and G. Aubel-Sadron, FEBS Lett., 142, 17 (1982). 78 K. Sugioka, H. Nakano, T. Noguchi, J. Tsuchiya, and M. Nakano, Biochem. Biophys. Res. Commun., 100, 1251 (1981). 79 C. E. Myers, L. Gianni, C. B. Simone, R. Klecker, and R. Greene, Biochemistry, 21, 1707 (1982). 80 H. Muliawan, M. E. Scheulen, and H. Kappus, Biochem. Pharmacol., 31, 3147 (1982). 81 M. E. Scheulen, H. Muliawan, and H. Kappus, see Ref. 8, p. 159. 82 T. Facchinetti, M. Müh-Zange, M. Salmona, M. Carini, and H. Remmer, Chem. Biol. Interact., 38, 357 (1982). 83 A. Suarato, S. Penco, A. Vigevani, and F. Arcamone, Carbohyd. Res., 98, c1 (1981). 84 J. Boivin, M. Pais, and C. Monneret, Carbohyd. Res., 79, 193 (1980). 85 M. Menozzi, L. Valentini, E. Vannini, and F. Arcamone, J. Pharm. Sci., to appear. 86 F. Formelli and A. M. Casazza, Proceedings of the 5th International Symposium on Future Trends in Chemotherapy, Tirrenia, Italy, May 24–26, 1982. 87 F. Villani, E. Monti, L. Favalli, and F. Piccinini, Proceedings of the 13th International Cancer Congress, Sept. 8–15, 1982, Seattle (USA). 88 B. T. Hill and R. D. H. Whelan, Tumori, 68, 29 (1982). 89 S. E. Salmon, R. M. Liu, and A. M. Casazza, Cancer Chemother. Pharmacol., 6, 103 (1981). 90 H. Schwartz and P. M. Kanter, Cancer Lett., 13, 309 (1981). 91 A. Martini, E. Moro, M. A. Pacciarini, V. Tamassia, N. Natale, and E. Piazza, Eur. J. Cancer, in press (1982). 92 V. Bonfante, G. Bonadonna, F. Villani, and A. Martini in Recent Results in Cancer Research, Vol. 74, Springer, Berlin, 1980, pp. 202–209. 93 P. K. Schauer, R. E. Wittes, R. J. Gralla, E. S. Casper, and C. W. Young, Cancer Clinical Trials, 4, 433 (1981). 94 F. Pannuti, C. M. Camaggi, E. Strocchi, M. Giovannini, N. Canova, and V. Tamassia, see Ref. 87, Abs. 838, p. 147. 95 C. Italia, L. Paglia, E. Piazza, S. Luchini, A. Trabattoni, L. Beretta, and N. Natale, see Ref. 87, Abs. 831, p. 146. 96 F. Ganzina, International Symposium of 4′-epi-Adriamycin, Tokyo (Japan), Nov. 12, 1982. 97 S. S. Jew, S. Terashima, and K. Koga, Chem. Pharm. Bull., 27, 2351 (1979). 98 S. Terashima, N. Tanno, and K. Koga, Tetrahedron Lett., 21, 2753 (1980). 99 S. Terashima and K. Tamoto, Tetrahedron Lett., 23, 3715 (1982). 100 M. Parameswara Reddy and G. S. Krishna Rao, Tetrahedron Lett., 22, 3549 (1981). 101 S. Del Nero, C. Gandolfi, P. Lombardi, and F. Arcamone, Chem. Ind., 22, 810 (1981). 102 S. Del Nero and P. Lombardi, manuscript in preparation. 103 A. V. Rama Rao, V. H. Deshpande, and N. Laxma Reddy, Tetrahedron Lett. 23, 4373 (1982). 104 Y. Bessiere and P. Vogel, Helv. Chim. Acta, 63, 232 (1980). 105 J. S. Swenton, D. K. Anderson, D. K. Jackson, and L. Narasimhan, J. Org. Chem., 46, 4825 (1981). 106 F. A. J. Kerdesky, R. J. Ardecky, M. V. Lakshmikantham, and M. P. Cava, J. Am. Chem. Soc., 103, 1992 (1981). 107 R. J. Ardecky, D. Dominguez, and M. P. Fava, J. Org. Chem., 47, 409 (1982). 108 D. A. Jackson and R. J. Stoodley, J. Chem. Soc. Chem. Commun., 478 (1981). 109 M. J. Broadhurst, C. H. Hassal and G. J. Thomas, J. Chem. Soc. Perkin Trans. I, 2249 (1982). 110 F. Arcamone, Symposium on Anthracyclines, Paris, June 24–25, 1981. 111 F. Arcamone, in Structure-Activity Relationships of Anti-Tumor Agents, Developments in Pharmacology, Vol. 3, p. 111, D. N. Reinhoudt, T. A. Connors, H. M. Pinedo and K. W. van de Poll, Eds., Publisher, City, 1983. 112 A. M. Casazza, C. Bertazzoli, G. Pratesi, O. Bellini, and A. Di Marco, Proceedings 15th Annual Meeting of Clinical Oncology, New Orleans May 1979, Vol. 20 abstr. N. 63, p. 16. 113 A. M. Casazza, G. Pratesi, F. Giuliani, and A. Di Marco, Tumori, 66, 549 (1980). 114 F. Formelli, A. M. Casazza, A. Di Marco, A. Mariani, and C. Pollini, Cancer Chemother. Pharm., 3, 261 (1979). 115 G. Massa, C. Bogliolo, F. D'Amore, C. Mazzulini, R. Ghio, and I. Pannaciulli, J. Nat. Cancer Inst., 68, 971 (1982). 116 M. A. Pacciarini, A. Martini, E. Moro, and V. Tamassia, see Ref. 87, Abs. 2319, p. 406. 117 A. M. Casazza, B. Barbieri, A. Fumagalli, and M. C. Geroni, AACR Annual Meeting, May 25–28, 1983, San Diego, Cal. 118 M. Varini, S. Kaplan, P. Togni, and F. Cavalli, 7th Annual Meeting of the European Society for Medical Oncology, Lausanne, Oct. 28–31, 1981, Abs. 05–0374. 119 V. Bonfante, L. Ferrari, F. Villani, and G. Bonadonna, submitted to Investigational New Drugs. 120 N. Hoffman, L. Miller, L. Steinherz, C. Hancock, D. Miller, P. Steinberz, and C. Tan, ASCO Meeting, San Francisco, CA, May 22–24, 1983. 121 G. Lambertenghi-Deliliers, E. Pogliani, A. T. Maiolo, and E. E. Polli, 3rd International Symposium on Therapy of Acute Leukemias, Rome, Dec. 11–14, 1982. 122 F. Arcamone, G. Cassinelli, and S. Penco, see Ref. 6, p. 59. 123 F. C. Giuliani and N. O. Kaplan, Cancer Res., 40, 4682 (1980). 124 F. C. Giuliani, K. A. Zirvi, N. O. Kaplan, and A. Goldin, Int. J. Cancer, 27, 5 (1981). 125 G. Savi, A. M. Casazza, and F. Giuliani, Tumori, 67, 183 (1981). 126 C. Bertazzoli, U. Sammartini, F. Balconi, C. Rovero, A. Nasini, I. Dell'Oro, V. Antongiovanni, M. G. Tosana, and B. Lux, see Ref. 87, Abs. 2325, p. 407. 127 L. Rausa, N. D'Alessandro, L. Dusonchet, M. Crescimanno, L. Crosta, C. Flandina, S. Palmeri, and R. Sanguedolce, see Ref. 87, Abs. 2324, p. 407. 128 F. Formelli, C. Pollini, A. M. Casazza, A. Di Marco and A. Mariani, Cancer Chemother. Pharmacol., 5, 139 (1981). 129 M. Piccart, M. Bozencweig, C. Nicaise, M. Beer, N. Crespeigne, L. Anton Aparicio, M. van Rijmenant, and Y. Kenis, see Ref. 117. 130 L. Ferrari, A. Rossi, C. Brambilla, F. Villani, V. Bonfante, and G. Bonadonna, see Ref. 117. 131 C. Sessa, S. Kaplan, E. Kaplan, M. Varini, and F. Cavalli, see Ref. 120. 132 E. M. Acton, C. W. Mosher, and J. M. Gruber, see Ref. 6, p. 119. 133 C. W. Mosher, H. Y. Wu, A. N. Fujiwara and E. M. Acton, J. Med. Chem., 25, 18 (1982). 134 Y. Takahashi, M. Kinoshita, T. Masuda, K. Tatsuta, T. Takeuchi, and H. Umezawa, J. Antibiot., 35, 117 (1982). 135 B. A. Sela and Y. Levin, Cancer Treat. Rep., 65, 277 (1981). 136 M. Masquelier, R. Baurain and A. Trouet, J. Med. Chem., 23, 1166 (1980). 137 R. S. Jaenke, D. Deprez-de Campenere and A. Trouet, Cancer Res., 40, 3530 (1980). 138 D. Deprez-deCampenere, R. Baurain and A. Trouet, Cancer Chemother. Pharmacol., 8, 193 (1982). 139 H. Umezawa, Y. Takahashi, K. Kinoshita, H. Naganawa, T. Masuda, M. Ishizuka, K. Tatsuta, and T. Takeuchi, J. Antibiot., 32, 1082 (1979). 140 T. Tsuruo, H. Iida, S. Tsukagoshi and Y. Sakurai, Cancer Res., 42, 1462 (1982). 141 D. Horton, R. G. Nickol, W. Weckerle, and E. Winter-Muhaly, Carbohyd. Res., 76, 269 (1979). 142 J. Boivin, A. Montagnac, C. Monneret, and M. Pais, Carbohyd. Res., 85, 223 (1980). 143 A. Di Marco, T. Skovsgaard, A. M. Casazza, G. Pratesi, N. I. Nissen, and K. Danø, Cancer Chemother. Pharmacol., 7, 15 (1981). 144 A. Bargiotti, A. M. Casazza, G. Cassinelli, A. Di Marco, S. Penco, G. Pratesi, R. Supino, A. Zaccara, F. Zunino, and F. Arcamone, Cancer Chemother. Pharmacol., 10, 84 (1983). 145 F. Sztaricskai, M. Menyhart, R. Bognar, and A. Neszmelyi, Carbohyd. Res., 100, C14 (1982). 146 M. Israel and R. J. Murray, J. Med. Chem., 25, 24 (1982). 147 D. Horton, W. Priebe, and W. R. Turner, Carbohyd. Res., 94, 11 (1981). 148 D. Horton and W. Priebe, J. Antibiot., 34, 1019 (1981). 149 D. Horton and W. Priebe, see Ref. 6, p. 197. 150 H. S. El Khadem, D. Matsuura, D. L. Swartz, and R. Cermak, see Ref. 6, p. 253. 151 M. Israel, J. E. Airey, R. J. Murray, and J. W. Gillard, J. Med. Chem., 25, 28 (1982). 152 H. S. El Khadem and D. Matsuura, Carbohyd. Res., 101, C1 (1982). 153 H. Tanaka, T. Yoshioka, Y. Shimauchi, Y. Matsushita, Y. Matsuzawa, T. Oki, and T. Ishikura, J. Antibiot., 35, 312 (1982). 154 C. Monneret, J. Boivin, A. Martin, and M. Pais, see Ref. 6, p. 225. 155 S. Penco, A. M. Casazza, G. Franchi, B. Barbieri, O. Bellini, A. Podestà, G. Savi, G. Pratesi, C. Geroni, A. Di Marco, and F. Arcamone, submitted to Cancer Treat. Rep. 156 B. Barbieri, O. Bellini, G. Savi, C. Bertazzoli, S. Penco, and A. M. Casazza, see Ref. 86. 157 A. M. Casazza, see Ref. 110. 158 T. Oki, A. Yoshimoto, T. Inui, T. Takeuchi, and H. Umezawa, European Patent 79103393.9 (Sept. 11, 1979). 159 J. W. Lown, H. H. Chen, J. A. Plambeck, and E. M. Acton, Biochem. Pharmacol., 31, 575 (1982). 160 R. I. Glazer, K. D. Hartman, and C. L. Richardson, Cancer Res., 42, 117 (1982). 161 L. A. Zwelling, D. Kerrigan, and S. Michaels, Cancer Res., 42, 2687 (1982). 162 G. Cassinelli, F. Di Matteo, S. Forenza, M. C. Ripamonti, D. Ruggieri, A. Vigevani, and F. Arcamone, Il Farmaco, Ed. Sci., 37, 501 (1982). 163 V. H. DuVernay, J. A. Pachter, and S. T. Crooke, Cancer Res., 40, 387 (1980). 164 G. Cassinelli, F. Di Matteo, S. Forenza, M. C. Ripamonti, G. Rivola, F. Arcamone, A. Di Marco, A. M. Casazza, C. Soranzo, and G. Pratesi, J. Antibiot., 33, 1468 (1980). 165 F. Arcamone, G. Cassinelli, F. Di Matteo, S. Forenza, M. C. Ripamonti, G. Rivola, T. McCabe, and J. Clardy, J. Am. Chem. Soc., 102, 1462 (1980). 166 H. Umezawa, Y. Takahashi, H. Naganawa, K. Tatsuta, and T. Takeuchi, J. Antibiot., 33, 1581 (1980). 167 S. Penco, F. Angelucci, F. Arcamone, M. Ballabio, G. Barchielli, G. Franceschi, A. Suarato, and E. Vanotti, J. Org. Chem., 48, 405 (1983). Citing Literature Volume4, Issue2April/June 1984Pages 153-188 ReferencesRelatedInformation
Publication Year: 1984
Publication Date: 1984-04-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 93
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot